We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Multifunctional Microplate Reader Now Available

By LabMedica International staff writers
Posted on 01 Sep 2010
Life science and biotech researchers now have available a state-of-the-art microplate reader with a wide range of capabilities from UV-Vis absorbance to bottom fluorescence and luminescence. More...


The BioTek Instruments, Inc. (Winooski, VT, USA) Synergy H1 Hybrid Multi-Mode Microplate Reader is a flexible monochromator-based multimode microplate reader. The monochromator optics uses a third generation quadruple-grating design that allows working at any excitation or emission wavelength with a one-nanometer step. This system supports top and bottom fluorescence intensity, UV-visible absorbance, and high-performance luminescence detection. It can handle all the standard microplate applications found in life science research laboratories.

A filter module is available as a completely independent add-on that includes its own light source, and a high performance dichroic-based wavelength selection system. With its very high optical efficiency, this module supports advanced detection modes such as Fluorescence Polarization, Time-Resolved Fluorescence and filtered luminescence (e.g.,  BRET).

A dual reagent injection system is available to automate inject/read assays such as ion channels assays or flash luminescence assays (e.g., luciferase or ATP assays). The Synergy H1 incorporates BioTek's Gen5 Data Analysis Software for advanced reader control, data analysis, graphing, exporting, and reporting. Additionally, Synergy H1 is compatible with BioTek's Take3 Multi-Volume Plate that measures up to 16 two-microliter samples, two BioCells or a standard cuvette for fast and simple multivolume, multisample analysis.

"Synergy H1 provides robust performance and for the first time makes "Hybrid Technology” available to life science, academic, and small biotechnology companies at a very competitive price,” said Gary Barush, director of marketing and sales at BioTek. "The modular architecture means that customers can easily upgrade from a monochromator-based multimode reader to a hybrid reader offering true versatility and unlimited assay use.”

Related Links:
BioTek Instruments, Inc.



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.